By Deployment Mode (On-premise & Cloud), By End Use, By Region -Market Forecast, 2025-2034
The global scientific data management system market size was valued at USD 121.95 million in 2024 and is anticipated to grow at a CAGR of 44.00% from 2025 to 2024. Key factors driving demand for scientific data management system include complexity of scientific data, growing adoption of lab automation, rising focus on digital transformation, and increasing emphasis on data accuracy and governance mandates.
The growth of this market is driven by increasing scientific studies and research that has boosted the count of technologically superior research laboratories requiring key software applications to store substantial amount of data, share and securely manage large quantities of crucial scientific data and information, thus, resulting in SDMS market expansion. Moreover, the COVID-19 pandemic worldwide has forced people to maintain social-distancing, governments to implement longer lockdowns. The lockdown implemented by the governments has resulted in notable shortage of employees or scientists doing research at the laboratories. This situation has driven the need for the deployment of an advanced scientific data management system to securely store the scientific data thereby, contributing to market growth.
To Understand More About this Research: Request a Free Sample Report
Growth Drivers
Substantial clinical trials for development of novel and effective medicines used to treat chronic diseases such as diabetes, cancer, asthma, etc. also generates huge amount of crucial scientific data that demands for secure data storage solutions, thereby, boosting market growth. For instance, according to the U.S. National Library of Medicine in March 2020, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, initiated a phase-4 clinical trial to determine the pathogen and efficacy evaluation of Metagenomics second generation sequencing technology for precision therapy on the infected patients. The study is estimated to be completed on September 30, 2023. In addition, in April 2020, Medical University Innsbruck initiated a phase-3 clinical trial to determine the effectiveness of daflon drug in the treatment of proctitis radiation. The study is estimated to be completed on August 26, 2023. These clinical trials also generate significant amount of crucial scientific data that requires secure storage solutions thereby, driving the demand for the market.
Know more about this report: request for sample pages
The high prevalence of contagious diseases including, COVID-19 pandemic has encouraged the laboratory researchers and scientists to proactively implement SDMS solutions for securing the key scientific data generated during their ongoing laboratory researches. This stored scientific data can later be used by the scientists for future reference or continuing their research after pandemic calms down. The growing incidence of infectious diseases worldwide is also increasing the use of scientific data management system. The need for rapid, accurate, and large-scale data collection, sharing, and analysis becomes critical for infectious disease surveillance and outbreak response.
The market is primarily segmented on the basis of deployment Mode, By end use, and geographic region.
By Deployment Mode |
By End Use |
By Region |
|
|
|
Know more about this report: request for sample pages
Based upon deployment mode, the global market is categorized into on-premise and cloud. The cloud-based deployment mode segment is expected to hold a major revenue share in the coming years. The dominant is attributed to extensive advancements in cloud-based solutions for SDMS and notable investment by the companies in development of novel cloud-based SDMS solutions. In addition, there’s substantial adoption of cloud-based SDMS solutions across the research laboratories due to their ease of implementation, low implementation cost as compared to the on-premise SDMS solutions. The high security offered by cloud-based solutions also contributed to the segment growth.
Based upon end-use, the global market is categorized into hospitals, laboratory and research institutes. The laboratory segment dominanated the revenue share in 2024. This is due to increasing number of day-to-day laboratory-based experiments that results in huge generation of key scientific data. This scientific data requires effective SDMS solutions to securely store the data to be used by the researchers and scientists in their ongoing laboratory-based researches. Additionally, there’s significant demand for high-end SDMS solutions all through the research laboratories globally since they usually exchange key scientific data with their partner institutions. The SDMS allow to capture strategic scientific data from a number of remote locations and uniquely imports, securely save data into the common data repositories. The secure storage of scientific data into the common repository makes it easy for the scientists and other research professionals to conveniently extract the data for their ongoing research.
The implementation of SDMS across the hospitals worldwide is further boosting hospital segment growth. Technologically-advanced SDMS solutions are used in hospitals to securely store medical records, patient current medical information and patient’s health history. Furthermore, SDMS also develops a highly customized workflow while enabling the healthcare professionals to timely review the patient’s medical records and administer the relevant medicines for the treatment of diseases, making it highly important in hospitals.
North America dominated the global market share in 2024 due to to favorable government policies that support the use of scientific data management system and high level of digital literacy among the individuals in the region. Also, COVID-19 pandemic led the the government of United States to proactively focus on maintaining safe-distancing even across the scientific research laboratories. Thie healthcare spending and growing research in the development of medicene for chronic people, particualry aging population.
Europe SDMS market growth is mainly driven by governments in the countries such as United Kingdom (UK), Germany, and France focusing on implementing social-distancing rules to prevent the spread of COVID-19 coronavirus-driven disease. Such a policy adopted by the governments in the region is expected to fuel the demand for scientific data management system in the region in order to securely exchange the scientific data between the research institutions and the researchers or scientists, while avoiding the requirement to visit research laboratory. Furthermore, the ongoing research on development of highly effective and low-cost medicine to treat COVID-19 spread across Europe also generates a huge amount of crucial scientific data that needs to be stored securely. This is also expected to boost the demand for region’s growth.
Asia Pacific SDMS market growth is attributed to high incidence of chronic diseases such as cancer, diabetes, asthma, among several others. The large occurrence of these diseases generates huge amount of data across the research laboratories that are involved in developing effective medicines for the treatment of the disease. This requirement is expected to boost the demand for scientific data management system in Asia-Pacific region while contributing to regional market growth.
Players in the market are focusing on product development and acquisition strategies to strengthen their market position while also boost their product portfolio. For instance, in August 2019, Merck has acquired ProcessPad platform, a key data analysis and data management platform that is used for monitoring and strategic reporting of key scientific processes in the real-time from Simplyfeye Software Private Ltd.
Some of the major players operating the scientific data management system market include, TIBCO Software Inc., Shimadzu Corporation, Merck KGaA, SciCord LLC, LabVantage Solutions Inc., LabConnect, LLC, Accelerated Technology Laboratories Inc., Abbott Laboratories, and Thermo Fisher Scientific Inc.
August 2025, LabConnect, LLC announced the launch of LabConnector, a powerful new technology solution that transforms the way laboratory data is exchanged and managed for clinical trials.
Report Attributes |
Details |
Market Size in 2024 |
USD 121.95 Million |
Market Size in 2025 |
USD 175.37 Million |
Revenue Forecast by 2034 |
USD 4,668.89 Million |
CAGR |
44.00% from 2025 to 2034 |
Base Year |
2024 |
Historical Data |
2020–2023 |
Forecast Period |
2025–2034 |
Quantitative Units |
Revenue in USD Million and CAGR from 2025 to 2034 |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
Segments Covered |
|
Regional Scope |
|
Competitive Landscape |
|
Report Format |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
• The global market size was valued at USD 121.95 million in 2024 and is projected to grow to USD 4,668.89 million by 2034.
• The global market is projected to register a CAGR of 44.00% during the forecast period.
• North America dominated the market in 2024
• A few of the key players in the market are TIBCO Software Inc., Shimadzu Corporation, Merck KGaA, SciCord LLC, LabVantage Solutions Inc., Accelerated Technology Laboratories Inc., Abbott Laboratories, and Thermo Fisher Scientific Inc.
• The cloud segment dominated the market revenue share in 2024.
• The hospitals segment is projected to witness the fastest growth during the forecast period.